Best Peptide for Gut Health
BPC-157, Larazotide, KPV & VIP Peptide — Ranked for IBS, IBD & Leaky Gut (2026)
Gut-healing peptides address three core mechanisms of gut dysfunction: mucosal damage and repair (BPC-157), intestinal permeability (Larazotide), and mucosal inflammation (KPV). BPC-157 is the most comprehensively studied gut peptide with data spanning IBD, NSAID-induced ulcers, fistulas, and gut motility. Together these peptides cover the spectrum from structural repair to immune modulation to barrier integrity. Track your gut protocol in Shotlee.
Top Gut Health Peptides — Ranked by Evidence
| Peptide | Mechanism | Best Evidence | Delivery | Evidence Level |
|---|---|---|---|---|
| BPC-157 | VEGF angiogenesis, NO pathway, EGR-1 collagen — mucosal repair | Extensive animal models (IBD, ulcers, fistulas); clinical use | Oral (arginine salt) or SC injection | ⭐⭐⭐⭐ |
| Larazotide Acetate | Zonulin antagonist — tight junction regulation, permeability | Phase 2/3 trials in celiac disease; permeability reduction data | Oral capsule | ⭐⭐⭐⭐ |
| KPV | Alpha-MSH fragment — NF-kB inhibition, mucosal anti-inflammation | IBD animal models; colitis reduction data; Phase 1 data | Oral or SC injection | ⭐⭐⭐ |
| VIP Peptide | Vasoactive intestinal peptide — motility regulation, anti-inflammatory | Human data for IBD motility, immune dysregulation | Intranasal or SC injection | ⭐⭐⭐ |
| LL-37 | Cathelicidin antimicrobial peptide — gut microbiome defence | SIBO/dysbiosis animal data; gut barrier support | Oral or SC injection (caution) | ⭐⭐ |
| Glutathione | Antioxidant tripeptide — gut oxidative stress, mucosal protection (not a GI-specific peptide) | Oral/IV human data for oxidative gut conditions | IV or liposomal oral | ⭐⭐ |
Evidence level reflects depth of human gut-specific clinical data. BPC-157 and Larazotide have the most human evidence for gut indications. [1, 2, 3]
Top Gut Health Picks Explained
BPC-157 — The #1 Gut Healing Peptide
Larazotide Acetate — Leaky Gut Repair
KPV — IBD Inflammation Control
VIP Peptide — Motility and Immune Balance
LL-37 — Gut Antimicrobial Defence
How to Choose the Right Gut Health Peptide
For most gut health goals, BPC-157 is the first-choice peptide because it addresses the broadest range of gut pathology — structural mucosal damage, inflammation, vascularity, and motility — in a single compound. Use the oral arginine salt form for gut-targeted delivery. If leaky gut (intestinal permeability) is the primary issue, add Larazotide to the protocol for specific tight junction repair that BPC-157 does not directly provide.
For active IBD flares (Crohn's, ulcerative colitis), the BPC-157 + KPV combination is well-established in functional medicine: BPC-157 handles structural repair and angiogenesis while KPV directly inhibits the NF-kB inflammatory cascade in gut tissue. VIP peptide is useful as an adjunct when gut motility is significantly dysregulated alongside inflammation.
Gut healing takes time — measure your progress objectively. Track daily symptom scores (bloating, pain, stool consistency), weekly energy levels, and any available biomarkers (faecal calprotectin, zonulin, CRP) in Shotlee. Gut peptide protocols typically require 4–12 weeks before full benefits are apparent.
Track Your Gut Protocol in Shotlee
Log every dose, daily gut symptom scores, and stool quality ratings in Shotlee. Track inflammatory markers and compare baseline to 4-week and 8-week measurements to quantify your gut healing progress.
How to Track Your Gut Health Protocol in Shotlee
Baseline: record your typical daily gut symptom scores — bloating (0–10), pain (0–10), stool consistency (Bristol Stool Scale), and energy level
Log each peptide dose with compound, dose, delivery route (oral vs injection), and time of day — for oral BPC-157, note whether it is arginine salt or acetate form
Rate your gut symptoms daily at a consistent time (e.g. evening) to build a trend over the protocol weeks
Track any available gut biomarkers: faecal calprotectin (IBD activity), zonulin (permeability), or CRP — compare pre-protocol to 6–8 week marks
Note food reactions separately — leaky gut repair often manifests as reduced food sensitivity symptoms before direct GI improvement
Frequently Asked Questions
BPC-157 (oral arginine salt form) is the most broadly effective gut health peptide — it addresses mucosal damage, inflammation, vascularity, and motility through multiple mechanisms. For leaky gut specifically, Larazotide has the most direct clinical trial evidence. For IBD inflammation, KPV is the strongest targeted anti-inflammatory peptide for gut tissue.
For gut health, always take BPC-157 orally. When swallowed, BPC-157 travels through the GI tract and exerts healing effects directly on the stomach, small intestine, and colon — its natural anatomical target. The arginine salt (arginate) form is significantly more stable in stomach acid than the standard acetate form. SC injection is used for systemic and musculoskeletal conditions, not primarily for gut healing.
Larazotide Acetate is the most targeted leaky gut peptide — it specifically blocks zonulin, the protein that opens tight junctions. It has Phase 2/3 clinical trial data for celiac disease (the most studied leaky gut condition). BPC-157 is a strong complement, providing broader mucosal repair. The BPC-157 + Larazotide combination addresses both structural repair and tight junction restoration.
Multiple peptides show promise for IBD in preclinical and early human data: BPC-157 heals mucosal lesions, KPV directly inhibits NF-kB inflammatory signalling in gut tissue, and VIP peptide modulates gut immune dysregulation. None are FDA-approved for IBD. They are used off-label in functional medicine protocols alongside conventional IBD management — never as replacements for prescribed IBD medications.
BPC-157 effects on acute gut symptoms (pain, bloating) can begin within 1–2 weeks. Structural mucosal healing — measurable by faecal calprotectin or endoscopy — typically takes 4–8 weeks. Larazotide effects on permeability can be measured within 2–4 weeks. Track your gut symptom scores daily in Shotlee to see your personal response timeline.
References
- [1]ReviewSikiric P, et al. "Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Curr Neuropharmacol. 2016;14(8):857-865.
- [2]Clinical TrialKelly CP, et al. "Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study." Aliment Pharmacol Ther. 2013;37(2):252-62.
- [3]ReviewDalmasso G, et al. "The Peptide KPV Inhibits the Cytokine-Induced Pro-inflammatory Response in Intestinal Epithelial Cells." J Cell Biochem. 2008;103(6):1927-1940.
Track Your Gut Health Protocol in Shotlee
Log every dose, daily symptom score, and gut biomarker. See your mucosal healing progress with clean trend data over your protocol weeks.
🚀 Use Shotlee for Free